AGN Media thread, page-209

Mate you calling out people pests that’s funny.

1. Is AGN its own drug class or unique? No
2. Has all peptides in the same drug class failed to get a response in humans? Yes
3. Has the company moved away in their presentations comparing itself to same peptides in the drug class? Yes
4. Are safety studies and preclinical studies cleared by previous peptides before they failed? Yes

The above answers tell you why I’m here. But apparently all you want to hear is the share price going to be pumping. Investigate the answers and if you have proof that this drug class works in humans post it and let’s have a discussion